Vidyya Medical News Service
Volume 7 Issue 32 Published - 14:00 UTC 08:00 EST 1-Feb-2005 Next Update - 14:00 UTC 08:00 EST 2-Feb-2005
little clear gif used for spacer

FDA clears the way for generic versions of transdermal patches to treat chronic pain
The Food and Drug Administration (FDA) has granted approval to Mylan Technologies, Inc., for the first generic version of Alza Corporation's Duragesic Patch (Fentanyl Transdermal System) used to treat patients suffering from severe chronic pain that cannot be managed with alternative analgesics.  more

Prescribing information: Duragesic (fentanyl transdermal system)
DURAGESIC® (fentanyl transdermal system)CII is indicated for patients in chronic pain who require continuous opioid analgesia and whose pain cannot be managed by lesser means such as acetaminophen-opioid combinations, nonsteroidal analgesics, or p.r.n. dosing with short-acting opioids.  more

Task force recommends that male smokers between the ages of 65 and 75 be screened for abdominal aortic aneurysm
Men between the ages of 65 and 75 who are or have been smokers should have a one-time ultrasound to screen for abdominal aortic aneurysm, according to a new recommendation from the U.S. Preventive Services Task Force. Nearly 70 percent of men in this age group have smoked and would benefit from routine screening to check for aneurysms.  more


List of cancer-causing agents grows
The Department of Health and Human Services released its Eleventh Edition of the Report on Carcinogens today, adding seventeen substances to the growing list of cancer-causing agents, bringing the total to 246. For the first time ever, viruses are listed in the report: hepatitis B virus, hepatitis C virus, and some human papillomaviruses that cause common sexually transmitted diseases. Other new listings include lead and lead compounds, X-rays, compounds found in grilled meats, and a host of substances used in textile dyes, paints and inks.  more

Testosterone supplements for elderly men
The University of Manchester has just launched trials to investigate whether increasing the testosterone levels of frail elderly men could improve their strength, energy and mobility.  more

Compound from rare plant shows promise in treating breast cancer
They started with a bare room and an idea. Now, after five years of painstaking, sophisticated tests, scientists at the University of Virginia Health System have discovered that a compound, derived from a rare South American plant, stops the growth of human breast cancer cells in laboratory cultures. more

Pro-inflammatory enzyme linked to diabetes; Immune system's macrophages may be key to treatment
An enzyme that initiates inflammation has been directly linked to insulin resistance and resulting type II diabetes by researchers at the University of California, San Diego (UCSD) School of Medicine. In addition, the team suggests that inhibition of the enzyme in the immune system's macrophages may be a new diabetes therapy. more

little clear gif used for a space